Synvoma is committed to building a globally leading "virtual patient" computing base.
Based on cross scale digital twin technology (from cells to the human body), we create a computable and verifiable virtual patient population to achieve system level simulation of disease mechanisms, drug action pathways, and treatment responses. On this basis, Synvoma connects the entire chain of new drug devel...